In this study, we investigated CCT3 and IQGAP3 at plasma levels in patients with HCC or cirrhosis and in healthy individuals, and evaluated their application in detecting small and AFP-negative tumors in patients with HCC. This evidence concerns the gene CCT3 and Cirrhosis.